The endocannabinoid system and schizophrenia: links to the underlying pathophysiology and to novel treatment approaches.
Department of Psychiatry, VACHS, 950 Campbell Ave, West Haven, CT 06516 swapnil.gupta@yale.edu.
Swapnil
S
Gupta
John D
JD
Cahill
Mohini
M
Ranganathan
Christoph U
CU
Correll
D063386:Cannabinoid Receptor Agonists / Q000494:pharmacology; D002186:Cannabinoids / Q000494:pharmacology*; D063388:Endocannabinoids / Q000096:biosynthesis / Q000502:physiology*; D006801:Humans; D043882:Receptors, Cannabinoid / Q000235:genetics / Q000378:metabolism*; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*
D063386:Cannabinoid Receptor Agonists; D002186:Cannabinoids; D063388:Endocannabinoids; D043882:Receptors, Cannabinoid